您的位置：山东大学 -> 科技期刊社 -> 《山东大学学报（医学版）》

山东大学学报 (医学版) ›› 2020, Vol. 1 ›› Issue (7): 38-46.doi: 10.6040/j.issn.1671-7554.0.2020.0557

• 临床医学 • 上一篇    下一篇

长链非编码RNA AL109955.1在80例结直肠癌组织中的表达及对细胞增殖与迁移侵袭的影响

李宁1,2,李娟1,2,谢艳1,2,李培龙1,2,王允山1,2,杜鲁涛1,2,王传新1,2   

  1. 1.山东大学第二医院检验医学中心, 山东 济南 250033;2.山东省肿瘤标志物检测工程实验室, 山东 济南 250033
  • 出版日期:2020-07-20 发布日期:2020-07-10
  • 通讯作者: 王传新. E-mail:cxwang@sdu.edu.cn
  • 基金资助:
    国家自然科学基金(81772271);山东省重大科技创新工程项目(2018YFJH0505);山东大学基本科研专项资金资助(2018JC002)

Expression of LncRNA AL109955.1 in 80 cases of colorectal cancer and its effect on cell proliferation, migration and invasion

LI Ning1,2, LI Juan1,2, XIE Yan1,2, LI Peilong1,2, WANG Yunshan1,2, DU Lutao1,2, WANG Chuanxin1,2   

  1. 1. Department of Clinical Laboratory, The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan 250033, Shandong, China;
    2. Tumor Marker Detection Engineering Laboratory of Shandong Province, Jinan 250033, Shandong, China
  • Online:2020-07-20 Published:2020-07-10

PDF (PC)

113

摘要： 目的 探讨长链非编码RNAs(LncRNAs)AL109955.1在结直肠癌(CRC)组织中的表达水平及其对CRC细胞增殖和迁移侵袭的影响。 方法 对癌症和肿瘤基因图谱(TCGA)中的CRC数据和基因型组织表达数据库(GTEx)中正常组织数据合并分析,筛选在CRC组织中低表达且与患者不良预后相关的LncRNAs,并通过实时荧光定量PCR(RT-qPCR)的方法在80例经病理学确诊的CRC组织及癌旁正常组织中验证其表达。采用细胞增殖检测试剂盒(CCK8)检测细胞增殖能力,以划痕实验和Transwell实验检测细胞迁移和侵袭能力。同时利用网页分析工具TargetScan和Tarbase,对下游miRNAs及其靶基因进行筛选和功能富集分析,使用cytoscape(3.7.2)软件构建LncRNA-miRNAs-mRNA的ceRNA调控网络。 结果 研究发现了一种新的LncRNA AL109955.1,其在CRC组织中的表达水平(1.18±2.46)较癌旁正常组织(1.81±1.65)明显降低(t=2.142,P=0.008)。进一步分析结果显示,AL109955.1的表达水平在不同分化程度的肿瘤组织中有差异［低分化:0.18(0.10~0.55)、中分化:0.49(0.22~1.81)、高分化:0.87(0.15~3.33)］;此外,随着肿瘤瘤体的增加,AL109955.1的表达水平逐渐降低［≥5 cm:0.26(0.11~0.62)、<5 cm:0.49(0.181~1.99)］,且差异具有统计学意义(U=570.5,P=0.020)。CCK8实验结果显示,AL109955.1能够显著抑制CRC细胞的增殖能力。划痕实验与Transwell实验结果则显示过表达AL109955.1后,细胞的迁移与侵袭能力明显下降。基因功能注释和基因通路富集分析显示AL109955.1可能通过影响Wnt、p53、Notch以及Jak-STAT等肿瘤经典信号通路从而发挥其生物学作用。 结论 LncRNA AL109955.1在CRC组织中的表达水平低于癌旁正常组织,并可抑制CRC细胞的增殖、迁移和侵袭。

关键词: 结直肠癌, 非编码RNA, 增殖, 迁移, 侵袭

Abstract: Objective To investigate the expression of long non-codingRNAs(LncRNAs)AL109955.1 in colorectal cancer(CRC)tissues and its effect on cell proliferation, migration and invasion. Methods The cancer genome atlas(TCGA)and genotype-tissue expression(GTEx)were analyzed to screen LncRNAs which were decreased in CRC tissues and related to the poor prognosis of patients, and then the expression in 80 pairs of CRC tissues and adjacent normal tissues was verified by quantitative real-time PCR(RT-qPCR). After that, the cell proliferation, migration and invasion were detected with cell counting kit-8(CCK8)test, wound healing test and Transwell assay, respectively. Finally, the miRNA binding sites and target mRNAs were screened with TargetScan and Tarbase, and a LncRNA-miRNAs-mRNA network was constructed with Cytoscape software(3.7.2). Results A novel LncRNA, AL109955.1, was screened and identified, and its expression was significantly lower in CRC tissues than that in adjacent normal tissues ［(1.18±2.46)vs(1.8±1.65), t=2.14, P=0.008］. AL109955.1 expressed differently in CRC tissues with different degrees of differentiation ［poorly differentiated: 0.18(0.10~0.55); moderately differentiated: 0.49(0.22~1.81); well differentiated: 0.87(0.15~3.33)］. In addition, AL109955.1 expression decreased with the increase of tumor size ［≥5 cm: 0.26(0.11~0.62); <5 cm: 0.49(0.181~1.99), U=570.5, P=0.020)］. CCK8 test showed AL109955.1 could significantly inhibit the proliferation of CRC cells. Wound healing test and Transwell assay showed overexpression of AL109955.1 significantly decreased the migration and invasion of CRC cells. Gene Ontology(GO)and Kyoto Encyclopedia of Genes and Genomes(KEGG)analysis indicated that AL109955.1 played its biological role by affecting classical tumor signaling pathways such as Wnt, p53, Notch and Jak-STAT. Conclusion LncRNA AL109955.1 expression is lower in CRC tissues than that in adjacent normal tissues. LncRNA AL109955.1 can inhibit the proliferation, migration and invasion abilities of CRC cells.

Key words: Colorectal cancer, Non-coding RNA, Proliferation, Migration, Invasion

中图分类号: 

  • R737.9
[1] Carr P R, Weigl K, Edelmann D, et al. Estimation of absolute risk of colorectal cancer based on healthy lifestyle, genetic risk, and colonoscopy status in a population-based study [J]. Gastroenterology, 2020, S0016-5085(20): 30337-30341.
[2] Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J]. CA Cancer J Clin, 2018, 68(6): 394-424.
[3] Sun N, Zhang L, Zhang C, et al. miR-144-3p inhibits cell proliferation of colorectal cancer cells by targeting BCL6 via inhibition of Wnt/beta-catenin signaling [J]. Cell Mol Biol Lett, 2020, 25: 19. doi: 10.1186/s11658-020-00210-3. eCollection 2020.
[4] Bonora M, Wieckowsk MR, Chinopoulos C, et al. Molecular mechanisms of cell death: central implication of ATP synthase in mitochondrial permeability transition [J]. Oncogene, 2015, 34(12): 1608. doi: 10.1038/onc.2014.462.
[5] Kadam PD, Chuan HH. Erratum to: Rectocutaneous fistula with transmigration of the suture: a rare delayed complication of vault fixation with the sacrospinous ligament [J]. Int Urogynecol J, 2016, 27(3): 505. doi: 10.1007/s00192-016-2952-5.
[6] Mcdonel P, Guttman M. Approaches for understanding the mechanisms of long noncoding RNA regulation of gene expression [J]. Cold Spring Harb Perspect Biol, 2019, 11(12): a032151. doi: 10.1101/cshperspect.a032151.
[7] Peng WX, Koirala P, Mo YY. LncRNA-mediated regulation of cell signaling in cancer [J]. Oncogene, 2017, 36(41): 5661-5667.
[8] Hua JT, Ahmed M, Guo H, et al. Risk SNP-mediated promoter-enhancer switching drives prostate cancer through lncRNA PCAT19 [J]. Cell, 2018, 174(3): 564-575.
[9] Wang Y, Lu JH, Wu QN, et al. LncRNA LINRIS stabilizes IGF2BP2 and promotes the aerobic glycolysis in colorectal cancer [J]. Mol Cancer, 2019, 18(1): 174. doi: 10.1186/s12943-019-1105-0.
[10] Fillon M. Study aims to improve colorectal cancer screening rates [J]. CA Cancer J Clin, 2019, 69(3): 161-163.
[11] Wong MC, Huang J, Lok V, et al. Differences in incidence and mortality trends of colorectal cancer, worldwide, based on sex, age, and anatomic location [J]. Clin Gastroenterol Hepatol, 2020, S1542-3565(20): 30196-30198.
[12] Pawa N, Arulampalam T, Norton JD. Screening for colorectal cancer: established and emerging modalities [J]. Nat Rev Gastroenterol Hepatol, 2011, 8(12): 711-722.
[13] 王唯全, 李萍, 王楚盈, 等. 结直肠癌的病因病机与药物治疗的研究进展[J]. 长春中医药大学学报, 2020, 36(1): 194-197. WANG Weiquan, LI Ping, WANG Chuying, et al. Advances in etiology, pathogenesis and drug therapy of colorectal cancer [J]. Journal of Changchun University of Chinese Medicine, 2020, 36(1): 194-197.
[14] Weng W, Goel A. Curcumin and colorectal cancer: An update and current perspective on this natural medicine [J]. Semin Cancer Biol, 2020, S1044-579X(20): 30044.
[15] Madunic K, Zhang T, Mayboroda OA, et al. Colorectal cancer cell lines show striking diversity of their O-glycome reflecting the cellular differentiation phenotype [J]. Cell Mol Life Sci, 2020. doi: 10.1007/s00018-020-03504-z. Online ahead of print.
[16] Fearon ER. Molecular genetics of colorectal cancer [J]. Annu Rev Pathol, 2011, 6: 479-507. doi: 10.1146/annurev-pathol-011110-130235.
[17] Cheng J, Meng J, Zhu L, et al. Exosomal noncoding RNAs in Glioma: biological functions and potential clinical applications [J]. Mol Cancer, 2020, 19(1): 66. doi: 10.1186/s12943-020-01189-3.
[18] Wang Y, Sun B, Wen X, et al. The roles of lncRNA in cutaneous squamous cell carcinoma [J]. Front Oncol, 2020, 2(10): 158. doi: 10.3389/fonc.2020.00158. eCollection 2020.
[19] Wu D, He X, Wang W, et al. Long noncoding RNA SNHG12 induces proliferation, migration, epithelial-mesenchymal transition and stemness of esophageal squamous cell carcinoma cells via post-transcriptional regulation of BMI1 and CTNNB1 [J]. Mol Oncol, 2020. doi: 10.1002/1878-0261.12683. Online ahead of print.
[20] Schier AC, Taatjes DJ. Structure and mechanism of the RNA polymerase II transcription machinery [J]. Genes Dev, 2020, 34(7-8): 465-488.
[21] Liu SJ, Malatesta M, Lien BV, et al. CRISPRi-based radiation modifier screen identifies long non-coding RNA therapeutic targets in glioma [J]. Genome Biol, 2020, 21(1): 83. doi: 10.1186/s13059-020-01995-4.
[22] Huang JZ, Chen M, Chen D, et al. A peptide encoded by a putative lncRNA HOXB-AS3 suppresses colon cancer growth [J]. Mol Cell, 2017, 68(1): 171-184.
[23] Zhao Y, Chu Y, Sun J, et al. LncRNA GAS8-AS inhibits colorectal cancer(CRC)cell proliferation by downregulating lncRNA AFAP1-AS1 [J]. Gene, 2019, 7(10): 140-144.
[24] Huo W, Qi F, Wang K. Long non-coding RNA FER1L4 inhibits prostate cancer progression via sponging miR-92a-3p and upregulation of FBXW7 [J]. Cancer Cell Int, 2020, 2(20): 64. doi: 10.1186/s12935-020-1143-0. eCollection 2020.
[25] Liu P, Wang H, Liang Y, et al. LINC00852 promotes lung adenocarcinoma spinal metastasis by targeting s100A9 [J]. J Cancer, 2018, 9(22): 4139-4149.
[26] Hong S, Yan Z, Song Y, et al. LncRNA AGAP2-AS1 augments cell viability and mobility, and confers gemcitabine resistance by inhibiting miR-497 in colorectal cancer [J]. Aging, 2020, 12(6): 5183-5194.
[1] 王晓磊 张海涛 张辉 郭成浩. 舒血宁注射液对高碘致培养血管内皮细胞损伤的保护作用[J]. 山东大学学报(医学版), 2209, 47(6): 38-.
[2] 赵舸,邹存华,宋冬冬,赵淑萍. 丹参酮IIA对子宫内膜癌细胞增殖与凋亡的影响[J]. 山东大学学报 (医学版), 2022, 60(9): 53-58.
[3] 张振伟,李佳,陈克明. IGF2BP2/m6A/ITGA5信号轴调控肾透明细胞增殖和迁移[J]. 山东大学学报 (医学版), 2022, 60(9): 74-84.
[4] 孙丽娜,杜晓晓,张红娟,孟金来. 人类白细胞抗原G调控蜕膜自然杀伤细胞促进滋养细胞侵袭[J]. 山东大学学报 (医学版), 2022, 60(6): 41-45.
[5] 申晓畅,孙一卿,颜磊,赵兴波. 芳基烃受体核转位因子样蛋白2在子宫内膜癌中的表达[J]. 山东大学学报 (医学版), 2022, 60(5): 74-80.
[6] 陈兆波,方敏,薛浩然,刘春艳. 去泛素化酶USP35促进非小细胞肺癌细胞迁移和侵袭[J]. 山东大学学报 (医学版), 2022, 60(4): 30-37.
[7] 钟黎黎,盛莹,郭江虹,阳双健,何宜静. LncRNA-UCA1通过靶向调控miR-182-5p对滋养细胞侵袭与转移的影响[J]. 山东大学学报 (医学版), 2022, 60(3): 76-82.
[8] 宋甜,付琳琳,王秋敏,杨晓,王莹,边月红,石玉华. 脂肪酸转运蛋白1在多囊卵巢综合征患者颗粒细胞中的表达[J]. 山东大学学报 (医学版), 2022, 60(2): 22-26.
[9] 亓梦雨,周敏然,孙洺山,李世洁,陈春燕. T大颗粒淋巴细胞白血病合并原发性骨髓纤维化1例[J]. 山东大学学报 (医学版), 2022, 60(2): 118-120.
[10] 李卉,姜朝阳,刘岩,张曼. 组蛋白去乙酰化酶SIRT1调控氧化低密度脂蛋白诱导巨噬细胞凋亡的表达[J]. 山东大学学报 (医学版), 2022, 60(1): 6-12.
[11] 王芳,陈华,商丽红,李茹月,李咏梅,杨玉娥,哈春芳. U0126对子宫内膜异位症大鼠MEK/ERK/NF-κB通路及增殖侵袭的影响[J]. 山东大学学报 (医学版), 2021, 59(9): 148-154.
[12] 李皖皖,周文凯,董书晴,贺士卿,刘钊,张家新,刘斌. 利用数据库信息构建乳腺癌免疫关联lncRNAs风险评估模型[J]. 山东大学学报 (医学版), 2021, 59(7): 74-84.
[13] 孙富云,王维鹏,张会会,耿艳,安小霞,李双双,张彬彬. 结直肠癌术后患者人格特质与抑郁、焦虑症状的关联性[J]. 山东大学学报 (医学版), 2021, 59(7): 91-96.
[14] 卢游,且迪,伍晋辉,杨凡. 干预Sonic Hedgehog信号通路对宫内发育迟缓新生大鼠学习记忆能力的影响[J]. 山东大学学报 (医学版), 2021, 59(5): 82-89.
[15] 孔雪,李娟,段伟丽,史爽,李培龙,杜鲁涛,毛海婷,王传新. 长链非编码RNA AC012073.1对乳腺癌细胞迁移侵袭的影响及临床价值[J]. 山东大学学报 (医学版), 2021, 59(4): 70-78.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
[1] 王焕亮,孙宝柱,杜洪玫,周长青,张丽. 不同麻醉监测指标调控异丙酚麻醉的比较[J]. 山东大学学报(医学版), 2006, 44(5): 471 -474 .
[2] 黄庆,田辉,李林,梁飞,刘贤锡 . 老年人肺癌组织中鸟氨酸脱羧酶基因表达及其临床意义[J]. 山东大学学报(医学版), 2006, 44(6): 556 -559 .
[3] 朱梅佳,韩巨,王新怡,鹿伟,王爱华,关心华,曹霞,曹秉振. 伴有皮层下梗死和白质脑病的常染色体显性遗传性脑动脉病临床病理研究[J]. 山东大学学报(医学版), 2006, 44(8): 834 -839 .
[4] 于慧1,2 ，陈少华1 ，赵家军2 ，高聆3
. 乙醇对人肝L02细胞糖原和GSK3β、PAMPK的影响[J]. 山东大学学报(医学版), 2009, 47(04): 75 -78 .
[5] 宋永红,马春红,吕红娟,朱传福,聂向民,王玫,刘艳,张萍 . 中国北方汉族人群HLA基因多态性研究[J]. 山东大学学报(医学版), 2007, 45(6): 546 -553 .
[6] 曾季平,王丽娜,王立祥,任晓辉,张孟业,夏文,崔行. 氯化锰致PC12细胞损伤的研究[J]. 山东大学学报(医学版), 2006, 44(5): 467 -470 .
[7] 舒雅,齐峰. 下颌角托在肥胖患者全麻诱导中的应用[J]. 山东大学学报(医学版), 2007, 45(10): 1072 -1074 .
[8] 宋海岩,武玉玲,张艳萍. 牡蛎提取物对高温致神经管畸形中凋亡细胞的保护作用[J]. 山东大学学报(医学版), 2007, 45(2): 113 -116 .
[9] 侯晓阳,卜培莉,张运,冯进波,刘春喜,李传保,郝明秀. 过氧化酶体增殖物激活受体α抑制血管紧张素Ⅱ促心肌纤维化作用的试验研究[J]. 山东大学学报(医学版), 2007, 45(7): 665 -668 .
[10] 王志刚,丁　璇,孙　鹏/sup>,王成伟,郝晓光,潘　顺 . 术前脑血管造影在血管内支架成形术治疗缺血性脑血管病中的应用[J]. 山东大学学报(医学版), 2007, 45(2): 146 -148 .
版权所有 © 2018 《山东大学学报(医学版)》编辑部　
地址:山东大学科技期刊社（济南市历城区山大南路27号山东大学中心校区明德楼B座721室） 电话: 0531-88366918 E-mail: xbyxb@sdu.edu.cn
本系统由北京玛格泰克科技发展有限公司设计开发